The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme
Open accessAbstract
OBJECTIVES: To demonstrate the benefits of using appropriate decision-analytic methods and value of information analysis (DA-VOI). Also to establish the feasibility and implications of applying these methods to inform the prioritisation process of the NHS Health Technology Assessment (HTA) programme, and possibly extending their use therein. DATA SOURCES: Three research topics that were considered by the HTA panels in the September 2002 and February 2003 prioritisation rounds. REVIEW METHODS: A brief and non-technical overview of DA-VOI methods was circulated to the panels and Prioritisation Strategy Group (PSG). For each case study the results were presented to the panels and the PSG in the form of brief case-study reports. Feedback on the DA-VOI analysis and its presentation was obtained in the form of completed questionnaires from panel members, and reports from panel senior lecturers and PSG members. RESULTS: Although none of the research topics identified met all of the original selection criteria for inclusion as case studies in the pilot, it was possible to construct appropriate decision-analytic models and conduct probabilistic analysis for each topic. In each case, the tasks were completed within the time-frame required by the existing HTA research prioritisation process. The brief case-study reports provided a description of the decision problem, a summary of the current evidence base and a characterisation of decision uncertainty in the form of cost-effectiveness acceptability curves. Estimates of value of information for the decision problem were presented for relevant patient groups and clinical settings, as well as the value of information associated with particular model inputs. The implications for the value of research in each of the areas were presented in general terms. Details were also provided on what the analysis suggested regarding the design of any future research in terms of features such as the relevant patient groups and comparators, and whether experimental design was likely to be required. CONCLUSIONS: The pilot study showed that, even with very short timelines, it is possible to undertake DA-VOI that can feed into the priority-setting process that has been developed for the HTA programme. There are however a number of areas that need to be established at the beginning of the process, such as clarification of the nature of the decision problem for which additional research is being considered, explicitness about which existing data should be used and how data that exhibit particular weaknesses should be down-weighted in the analysis. Other areas, including optimum application of researcher time, integrating the vignette (a summary of the clinical problem and existing evidence) and the use of DA-VOI, training, use of sensitivity analyses, and deployment of clinical expertise, are also considered in terms of the potential implementation of DA-VOI within the HTA programme. Recommendations for further research include how literature searching should focus on those variables to which the model's results are most sensitive and with the highest expected value of perfect information; methods of evidence synthesis (multiple parameter synthesis) to consider the evidence surrounding multiple comparators and networks of evidence; and ways in which the value of sample information can be used by the NHS HTA programme and other research funders to decide on the most efficient design of new evaluative research. There is also a need for an analytical framework to be developed that can jointly address the question of whether additional resources would better be devoted to additional research or interventions to change clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of serial measurements in medical research.
Matthews, J. N., Altman, D. G., Campbell, M. J., & Royston, P. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,136
Bayesian Approaches to Clinical Trials and Health‐Care Evaluation
Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P. (2003) · Wiley eBooks · doi:10.1002/0470092602 · Cited by 1,673
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Fenwick, E., Claxton, K., & Sculpher, M. (2001) · Health Economics · doi:10.1002/hec.635 · Cited by 1,110
Self-citationHoward, R. (1966) · IEEE Transactions on Systems Science and Cybernetics · doi:10.1109/tssc.1966.300074 · Cited by 995
Costs, effects and C/E‐ratios alongside a clinical trial
Van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 964
An Introduction to Markov Modelling for Economic Evaluation
Briggs, A., & Sculpher, M. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813040-00003 · Cited by 960
Self-citationClaxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Self-citationProbabilistic Sensitivity Analysis Using Monte Carlo Simulation: A Practical Approach
Doubilet, P., Begg, C. B., Weinstein, M. C., Braun, P., & McNeil, B. J. (1985) · Medical Decision Making · doi:10.1177/0272989x8500500205 · Cited by 860
Handling Uncertainty in Cost-Effectiveness Models
Briggs, A. H. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017050-00006 · Cited by 807
Bayesian methods in meta-analysis and evidence synthesis
Sutton, A. J., & Abrams, K. R. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000404 · Cited by 710
Introduction to Statistical Decision Theory.
Schervish, M. J., Pratt, J. W., Raiffa, H., & Schlaifer, R. (1996) · Journal of the American Statistical Association · doi:10.2307/2291759 · Cited by 705
Philips, Z., Ginnelly, L., Sculpher, M., Claxton, K., Golder, S., Riemsma, R., Woolacoot, N., & Glanville, J. (2004) · Health Technology Assessment · doi:10.3310/hta8360 · Cited by 697
Self-citationThe General Household Survey 1974
Hope, K., & O., H. M. S. (1978) · The British Journal of Sociology · doi:10.2307/589665 · Cited by 670
A social tariff for EuroQol: results from a UK general population surveyPreprint
Dolan, P., Gudex, C. M., Kind, P., & Williams, A. (1995) · RePEc: Research Papers in Economics · Cited by 611
Burden of Disease—Implications for Future Research
Michaud, C. M. (2001) · JAMA · doi:10.1001/jama.285.5.535 · Cited by 594
The Relation between Funding by the National Institutes of Health and the Burden of Disease
Gross, C. P., Anderson, G. F., & Powe, N. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402406 · Cited by 509
An economic approach to clinical trial design and research priority-setting
Claxton, K., & Posnett, J. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9 · Cited by 395
Self-citationSensitivity Analysis and the Expected Value of Perfect Information
Felli, J. C., & Hazen, G. B. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800117 · Cited by 327
Bayesian Approaches to Clinical Trials and Health-Care Evaluation
Best, M. A. (2005) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2004.00347_17.x · Cited by 303
NICE: faster access to modern treatments? Analysis of guidance on health technologies
Raftery, J. (2001) · BMJ · doi:10.1136/bmj.323.7324.1300 · Cited by 299
On the decision rules of cost-effectiveness analysis
Johannesson, M., & Weinstein, M. C. (1993) · Journal of Health Economics · doi:10.1016/0167-6296(93)90005-y · Cited by 288
Measurement of quality of life in end-stage renal disease: the time trade-off approach.
Churchill, D. N., Gw, T., Taylor, D. W., Barnes, C. C., LUDWIN, D., Shimizu, A., & Smith, E. K. (1987) · PubMed · Cited by 271
Technical Report: Urinary Tract Infections in Febrile Infants and Young Children
Downs, S. M. (1999) · Pediatrics · doi:10.1542/peds.103.4.e54 · Cited by 244
The Natural History of Bacteriuria in Childhood
Jodal, U. (1987) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30146-x · Cited by 226
Utility values associated with blindness in an adult population
Brown, M. M. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.3.327 · Cited by 221
The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment
Sculpher, M., Drummond, M., & Buxton, M. (1997) · Journal of Health Services Research & Policy · doi:10.1177/135581969700200107 · Cited by 208
Self-citationSenile disciform macular degeneration in the second eye.
Gregor, Z., Bird, A. C., & Chisholm, I. H. (1977) · British Journal of Ophthalmology · doi:10.1136/bjo.61.2.141 · Cited by 204
Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation
Critchfield, G. C., & Willard, K. E. (1986) · Medical Decision Making · doi:10.1177/0272989x8600600205 · Cited by 198
Analysis of serial measurements in medical research.
Senn, S. (1990) · BMJ · doi:10.1136/bmj.300.6725.680 · Cited by 194
Children with asthma have improved pulmonary functions after massage therapy
Field, T., Henteleff, T., Hernandez-Reif, M., Martinez, E., Mavunda, K., Kuhn, C., & Schanberg, S. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70317-8 · Cited by 174
Balon, J., Aker, P. D., Crowther, E. R., Danielson, C., Cox, P. G., O'Shaughnessy, D., Walker, C., Goldsmith, C. H., Duku, E., & Sears, M. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391501 · Cited by 174
Alexander, S. R., Arbus, G. S., Butt, K. M. H., Conley, S., Fine, R. N., Greifer, I., Gruskin, A. B., Harmon, W. E., McEnery, P. T., Nevins, T. E., et al. (1990) · Pediatric Nephrology · doi:10.1007/bf00869842 · Cited by 168
Unit Costs of Health and Social Care 1996
Netten, A., Rees, T., & Harrison, G. (1996) · Kent Academic Repository (University of Kent) · Cited by 161
Sutton, P. P., Parker, R. A., Webber, B. A., Newman, S. P., Garland, N., Lopez-Vidriero, M. T., Pavia, D., & Clarke, S. W. (1983) · PubMed · Cited by 151
Earliest Symptoms Caused by Neovascular Membranes in the Macula
Fine, A. M., Elman, M. J., Ebert, J. E., Prestia, P. A., Starr, J., & Fine, S. (1986) · Archives of Ophthalmology · doi:10.1001/archopht.1986.01050160069013 · Cited by 129
Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
Stinnett, A. A., & Mullahy, J. (1998) · National Bureau of Economic Research · doi:10.3386/t0227 · Cited by 110
Bateman, J. R. M., Newman, S. P., DAUNT, K. M., Sheahan, N. F., Pavia, D., & Clarke, S. W. (1981) · Thorax · doi:10.1136/thx.36.9.683 · Cited by 108
Ades, A. E., & Cliffe, S. (2002) · Medical Decision Making · doi:10.1177/027298902400448920 · Cited by 104
Setting priorities for research
Fleurence, R., & Torgerson, D. J. (2004) · Health Policy · doi:10.1016/j.healthpol.2003.11.002 · Cited by 94
Huovinen, P. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.10.1451 · Cited by 90
Health and Economic Outcomes Modeling Practices: A Suggested Framework
Halpern, M. T., Luce, B. R., Brown, R. E., & Genesté, B. (1998) · Value in Health · doi:10.1046/j.1524-4733.1998.120131.x · Cited by 79
Thompson, K. M., & Evans, J. S. (1997) · Risk Analysis · doi:10.1111/j.1539-6924.1997.tb00864.x · Cited by 77
Chronic asthma and chiropractic spinal manipulation: a randomized clinical trial
Nielsen, N. H., Brønfort, G., Bendix, T., Madsen, F., & Weeke, B. (1995) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1995.tb01006.x · Cited by 72
Selecting Treatments: A Decision Theoretic Approach
Claxton, K., Lacey, L. F., & Walker, S. G. (2000) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/1467-985x.00166 · Cited by 58
Self-citationLASER TREATMENTS WITH VERTEPORFIN THERAPY AND ITS POTENTIAL IMPACT ON RETINAL PRACTICES
Margherio, R. R., Margherio, A. R., & DESANTIS, M. E. (2000) · Retina · doi:10.1097/00006982-200007000-00001 · Cited by 54
Savcı, S., İnce, D. İ., & Arikan, H. L. (2000) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200001000-00006 · Cited by 53
Effects of chest physical therapy on lung function in children recovering from acute severe asthma
Asher, M. I., Douglas, C., Airy, M., Andrews, D., & Trenholme, A. A. (1990) · Pediatric Pulmonology · doi:10.1002/ppul.1950090305 · Cited by 47
PRIORITIZING INVESTMENTS IN HEALTH TECHNOLOGY ASSESSMENT
Davies, L. M., Drummond, M., & Papanikolaou, P. (2000) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300016172 · Cited by 45
Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy
Townsend, J. L., & Buxton, M. J. (1997) · Health Policy · doi:10.1016/s0168-8510(96)00870-6 · Cited by 34
Meads, C., Moore, D., & Hyde, C. (2003) · University of Birmingham Research Portal (University of Birmingham) · Cited by 17
Impact of Apolipoprotein(a) Phenotypes on Long-Term Renal Transplant Survival
Wahn, F., Daniel, V., Kronenberg, F., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251052 · Cited by 15
A Dynamic Programming Approach to Efficient Clinical Trial Design
Claxton, K., & Thompson, K. M. (2001) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 12
Self-citationMowatt, G., Vale, L. D., Perez, J. G. G., Wyness, L., Fraser, C. M., MacLeod, A., Daly, C., & Stearns, S. C. (2002) · Cited by 7
Manual therapy for asthma (Cochrane review)
(2001) · Journal of Osteopathic Medicine · doi:10.1016/s1443-8461(01)80026-5 · Cited by 4
Cited by
Philips, Z., Ginnelly, L., Sculpher, M., Claxton, K., Golder, S., Riemsma, R., Woolacoot, N., & Glanville, J. (2004) · Health Technology Assessment · doi:10.3310/hta8360 · Cited by 697
Self-citationAssessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Grosse, S. D. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.2.165 · Cited by 637
Liquid Compared With Conventional Cervical Cytology: A Systematic Review and Meta-analysis
Arbyn, M., Bergeron, C., Klinkhamer, P., Martin-Hirsch, P., Siebers, A. G., & Bulten, J. (2008) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000296488.85807.b3 · Cited by 443
Whither trial‐based economic evaluation for health care decision making?
Sculpher, M. J., Claxton, K., Drummond, M., & McCabe, C. (2006) · Health Economics · doi:10.1002/hec.1093 · Cited by 407
Self-citationEconomic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
Petrou, S., & Gray, A. (2011) · BMJ · doi:10.1136/bmj.d1766 · Cited by 292
Metadata
- Authors
- Claxton, K., Ginnelly, L., Sculpher, M., Philips, Z., & Palmer, S.
- Venue
- Health Technology Assessment
- Published
- 2004-07
- Volume
- 8
- Issue
- 31
- Pages
- 1-103, iii
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2065960788
- Cited by
- 258
- References
- 54
- FWCI
- 37.93
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.